Annovis Bio, Inc. (ANVS) — Stock Score Summary

Annovis Bio, Inc. (ANVS) has a MoatMap StockRank of 1/100 based on Quality (24/100), Value (27/100), and Momentum (15/100) factor scores. The current signal is STRONG SELL. Annovis Bio is a clinical-stage biotech company developing therapies for neurodegenerative diseases. It is a binary-event speculative play with zero revenue, high cash burn, and no structural moat, failing all our quality and margin of safety criteria.

Annovis Bio, Inc. is a clinical-stage drug platform company developing novel therapies to treat neurodegenerative diseases such as Alzheimer's and Parkinson's. The company's competitive moat is its lead compound, buntanetap, which targets multiple neurotoxic proteins simultaneously to restore axonal transport. It operates as a specialized biotechnology player focused on disease-modifying neuroprotective treatments.

Key Financial Metrics

Price$1.77
Market Cap$81M
P/E (Forward)-1.72
Price/Book3.21
Return on Equity-220.6%
Return on Invested Capital-170.2%
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-15M

Annovis Bio, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Annovis Bio, Inc.’s (ANVS) StockRank?
MoatMap’s StockRank for Annovis Bio, Inc. (ANVS) is 1/100, with a Strong Sell signal. It is a composite of Quality (24), Value (27), and Momentum (15) factor ranks across MoatMap’s 19,000+ stock universe.
Does Annovis Bio, Inc. have an economic moat?
Annovis Bio, Inc. (ANVS) has a Quality factor score of 24/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Annovis Bio, Inc. a buy, hold, or sell?
MoatMap’s current signal for Annovis Bio, Inc. (ANVS) is Strong Sell, based on a StockRank of 1/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Annovis Bio, Inc. in?
Annovis Bio, Inc. (ANVS) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksANVS deep dive reportAI ChampionsHow we score stocksSense-check another stock